1. Home
  2. LGL vs ICCC Comparison

LGL vs ICCC Comparison

Compare LGL & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGL
  • ICCC
  • Stock Information
  • Founded
  • LGL 1917
  • ICCC 1982
  • Country
  • LGL United States
  • ICCC United States
  • Employees
  • LGL N/A
  • ICCC N/A
  • Industry
  • LGL Industrial Machinery/Components
  • ICCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • LGL Technology
  • ICCC Health Care
  • Exchange
  • LGL Nasdaq
  • ICCC Nasdaq
  • Market Cap
  • LGL 39.1M
  • ICCC 39.2M
  • IPO Year
  • LGL N/A
  • ICCC 1987
  • Fundamental
  • Price
  • LGL $6.73
  • ICCC $5.42
  • Analyst Decision
  • LGL
  • ICCC
  • Analyst Count
  • LGL 0
  • ICCC 0
  • Target Price
  • LGL N/A
  • ICCC N/A
  • AVG Volume (30 Days)
  • LGL 5.3K
  • ICCC 15.8K
  • Earning Date
  • LGL 05-14-2025
  • ICCC 05-13-2025
  • Dividend Yield
  • LGL N/A
  • ICCC N/A
  • EPS Growth
  • LGL 66.76
  • ICCC N/A
  • EPS
  • LGL 0.08
  • ICCC N/A
  • Revenue
  • LGL $4,292,000.00
  • ICCC $26,493,169.00
  • Revenue This Year
  • LGL N/A
  • ICCC N/A
  • Revenue Next Year
  • LGL N/A
  • ICCC N/A
  • P/E Ratio
  • LGL $79.01
  • ICCC N/A
  • Revenue Growth
  • LGL 26.49
  • ICCC 51.63
  • 52 Week Low
  • LGL $4.86
  • ICCC $3.34
  • 52 Week High
  • LGL $7.28
  • ICCC $5.82
  • Technical
  • Relative Strength Index (RSI)
  • LGL 52.59
  • ICCC 61.98
  • Support Level
  • LGL $6.32
  • ICCC $4.56
  • Resistance Level
  • LGL $7.28
  • ICCC $5.05
  • Average True Range (ATR)
  • LGL 0.48
  • ICCC 0.25
  • MACD
  • LGL 0.01
  • ICCC 0.04
  • Stochastic Oscillator
  • LGL 64.52
  • ICCC 91.49

About LGL LGL Group Inc. (The)

LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Share on Social Networks: